Therabron Therapeutics' Series B - II Round

Therabron Therapeutics raised a round of funding on November 09, 2015.

Therabron Therapeutics, forrmerly Clarassance, is a clinical-stage biotechnology company that develops protein drugs to treat respiratory diseases. The company's products aim to restore the natural im…

Articles about Therabron Therapeutics' Series B - II Round: